FDA Inspection
Sterling Pharma USA LLCSterling Pharma USA LLC – FDA Inspection, Apr 4, 2018
Record Details
This FDA Inspection record concerns Sterling Pharma USA LLC, with an inspection on April 4, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 4c89c5f3-edb1-4d0b-93c6-8cdc9152ada4
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1049639
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
Other FDA inspections of Sterling Pharma USA LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| April 23, 2015 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Sterling Pharma USA LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.